Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review.

Brunasso AM, Puntoni M, Gulia A, Massone C.

Rheumatology (Oxford). 2011 Sep;50(9):1700-11. doi: 10.1093/rheumatology/ker190. Epub 2011 Jun 20. Review.

PMID:
21690185
2.

Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.

Ferri C, Ferraccioli G, Ferrari D, Galeazzi M, Lapadula G, Montecucco C, Triolo G, Valentini G, Valesini G; GISEA Group..

J Rheumatol. 2008 Oct;35(10):1944-9. Epub 2008 Aug 1.

PMID:
18688917
3.
5.

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.

Prignano F, Ricceri F, Pescitelli L, Zanieri F, Lotti T.

Br J Dermatol. 2011 Mar;164(3):645-7. doi: 10.1111/j.1365-2133.2010.10140.x. Epub 2011 Feb 7.

PMID:
21375517
6.

Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis.

Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L.

Rheumatology (Oxford). 2006 Oct;45(10):1294-7. Epub 2006 Apr 7.

PMID:
16603583
7.

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

Tobin AM, Kirby B.

BioDrugs. 2005;19(1):47-57. Review.

PMID:
15691217
8.

Treatment strategies for a patient with rheumatoid arthritis and hepatitis C.

Giannitti C, Bellisai F, Ferri C, Galeazzi M.

Expert Opin Pharmacother. 2009 Mar;10(4):579-87. doi: 10.1517/14656560902731951 . Review.

PMID:
19284361
10.

Infliximab treatment of rheumatoid arthritis and Crohn's disease.

Nahar IK, Shojania K, Marra CA, Alamgir AH, Anis AH.

Ann Pharmacother. 2003 Sep;37(9):1256-65. Review.

PMID:
12921510
11.

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting.

Navarro R, Vilarrasa E, Herranz P, Puig L, Bordas X, Carrascosa JM, Taberner R, Ferrán M, García-Bustinduy M, Romero-Maté A, Pedragosa R, García-Diez A, Daudén E.

Br J Dermatol. 2013 Mar;168(3):609-16. doi: 10.1111/bjd.12045.

PMID:
22985451
12.

The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.

Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S.

Int J Rheum Dis. 2009 Jul;12(2):118-24. doi: 10.1111/j.1756-185X.2009.01393.x.

PMID:
20374328
14.

Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.

Keating GM, Perry CM.

BioDrugs. 2002;16(2):111-48. Review.

PMID:
11985485
15.

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register..

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.

PMID:
16705046
16.

Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.

Carroll MB, Bond MI.

Semin Arthritis Rheum. 2008 Dec;38(3):208-17. doi: 10.1016/j.semarthrit.2007.10.011. Epub 2008 Jan 25. Review.

PMID:
18221983
17.

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.

Vassilopoulos D, Apostolopoulou A, Hadziyannis E, Papatheodoridis GV, Manolakopoulos S, Koskinas J, Manesis EK, Archimandritis AI.

Ann Rheum Dis. 2010 Jul;69(7):1352-5. doi: 10.1136/ard.2009.127233. Epub 2010 May 14.

PMID:
20472596
18.

Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis.

Moreland LW.

Pharmacoeconomics. 2004;22(2 Suppl 1):39-53. Review. Erratum in: Pharmacoeconomics. 2004;22(8):547.

PMID:
15157003
19.

Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection.

Bellisai F, Giannitti C, Donvito A, Galeazzi M.

Clin Rheumatol. 2007 Jul;26(7):1127-9. Epub 2006 Dec 2.

PMID:
17143590
20.

Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.

Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, Claudepierre P.

J Rheumatol. 2007 Feb;34(2):380-5. Epub 2006 Oct 1.

PMID:
17013997

Supplemental Content

Support Center